Search by Drug Name or NDC
NDC 60986-1008-03 Cholenest 2; 1; 8; 1; 8; 2; 1; 6; 1; 2 [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL Details
Cholenest 2; 1; 8; 1; 8; 2; 1; 6; 1; 2 [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL
Cholenest is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Marco Pharma International LLC.. The primary component is BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; COPPER; FRANGULA PURSHIANA BARK; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MORELLA CERIFERA ROOT BARK; SILYBUM MARIANUM SEED; SODIUM SULFATE; TARAXACUM OFFICINALE; VERONICASTRUM VIRGINICUM ROOT.
Product Information
NDC | 60986-1008 |
---|---|
Product ID | 60986-1008_d2bfd2b8-d3b7-e3bf-e053-2995a90a2901 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Cholenest |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Rhamnus purshiana, Carduus marianus, Taraxacum officinale, Chelidonium majus, Leptandra virginica, Myrica cerifera, Berberis vulgaris, Natrum sulphuricum, Magnesia phosphorica, Cuprum metallicum |
Product Type | HUMAN OTC DRUG |
Dosage Form | LIQUID |
Route | ORAL |
Active Ingredient Strength | 2; 1; 8; 1; 8; 2; 1; 6; 1; 2 |
Active Ingredient Units | [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL |
Substance Name | BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; COPPER; FRANGULA PURSHIANA BARK; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MORELLA CERIFERA ROOT BARK; SILYBUM MARIANUM SEED; SODIUM SULFATE; TARAXACUM OFFICINALE; VERONICASTRUM VIRGINICUM ROOT |
Labeler Name | Marco Pharma International LLC. |
Pharmaceutical Class | Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ov |
DEA Schedule | n/a |
Marketing Category | UNAPPROVED HOMEOPATHIC |
Application Number | n/a |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 60986-1008-03 (60986100803)
NDC Package Code | 60986-1008-3 |
---|---|
Billing NDC | 60986100803 |
Package | 50 mL in 1 BOTTLE, GLASS (60986-1008-3) |
Marketing Start Date | 2018-02-27 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 4b89ffcb-318b-416d-b13c-19fb94c2af70 Details
Active Ingredients
Cascara sagrada 1xHPUS
Milk thistle 1xHPUS
Dandelion 1xHPUS
Celadine 1xHPUS
Culver's root 2xHPUS
Bayberry 2xHPUS
Barberry 2xHPUS
Disodium sulfate 6xHPUS
Magnesium hydrogen phosphate 8xHPUS
Metallic copper 8XHPUS
The letters HPUS indicates that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of United Sates.
INGREDIENTS AND APPEARANCE
CHOLENEST
rhamnus purshiana, carduus marianus, taraxacum officinale, chelidonium majus, leptandra virginica, myrica cerifera, berberis vulgaris, natrum sulphuricum, magnesia phosphorica, cuprum metallicum liquid |
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
Labeler - Marco Pharma International LLC. (161994277) |
Registrant - Marco Pharma International LLC. (161994277) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Nestmann Pharma GmbH | 323426262 | manufacture(60986-1008) |
Revised: 12/2021
Document Id: d2bfd2b8-d3b7-e3bf-e053-2995a90a2901
Set id: 4b89ffcb-318b-416d-b13c-19fb94c2af70
Version: 5
Effective Time: 20211209